ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma

Li, Linjing*; Li, Xin; Zhang, Qingyan; Ye, Tao; Zou, Shuli; Yan, Jing南方医科大学; 兰州大学; 中山大学; 1
American Journal of Cancer Research2021DOI: 10.7150/jca.58168
5被引9阅读
引用收藏
分享

摘要

Introduction and objectives: Eukaryotic translation initiation factor 5A (EIF5A) is a member of the identified eIF family and played an important role in cell proliferation. There are few studies about the correlation between EIF5A and hepatocellular carcinoma (HCC). @@@ Materials and methods: We evaluated the expression of the EIF5A in human HCC cell lines and tissues by western blot analysis. Immunohistochemistry analysis of EIF5A was performed on a tissue microarray including 10 normal liver samples and 90 pathological section of HCC. Receiver operating characteristic (ROC) was introduced to obtain an optimal cut-off score for EIF5A positive expression. @@@ Results: Western blot results showed that EIF5A was highly expressed in HCC cell lines and tissues. Based on ROC curve analysis, 1/10 (10.0%) of normal hepatic tissues and 67/90 (74.4%) of HCC tissues were tested positive for EIF5A expression, which indicated that EIF5A were significantly up-regulated in HCC tissues compared with normal liver tissues (chi(2)=17.177, P<0.001). Furthermore, expression of EIF5A was significantly correlated with histological grade (P=0.048), clinical stage (P=0.003) and pT stage (P=0.003) but not correlated with sex (P=0.617) and age (P=0.831). @@@ Conclusions: In our study, we demonstrated the expression of EIF5A is closely correlated with HCC. In consideration of its relationship with clinicopathological parameters including histological grade, clinical stage and pT stage of HCC, EIF5A could be a potential biomarker.

学科与关键词

关键词
EIF5AHepatocellular carcinomaTissue microarrayDiagnostic biomarkerClinicopathological parameters
相关
加载中…
  • IGF2BP3-induced activation of EIF5B contributes to progression ofhepatocellular carcinoma cells br
    LI, Xiaoyin; Wang, Qian; Liang, Hongfeng; Chen, Shisheng; Chen, Haiwen; Lu, Yaoyong*; Yang, Changfu*Oncology Research, 2022, 30(2): 77-87.
  • eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway
    Sun, Liping; Liu, Shuguang; Wang, Xiaopai; Zheng, Xuefeng; Chen, Ya; Shen, Hong*Journal of Translational Medicine, 2021, 19(1): 216.被引 16
  • The expression and clinical significance of TPM4 in hepatocellular carcinoma
    Li, Linjing*; Ye, Tao; Zhang, Qingyan; Li, Xin; Ma, Li; Yan, JingInternational Journal of Medical Sciences, 2021, 18(1): 169-175.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
American Journal of Cancer Research
发表日期
2021
卷期
第 12 卷, 第 16 期
页码
4774-4779
DOI
10.7150/jca.58168
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82060531]; Internationally Technological Cooperation Project of Gansu Province [18YF1WA117]; Longyuan Youth Creative and Innovative talents Project of Gansu Province [2020RCXM149]; Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital [CY2018-MS11]; Science and Technology Development Guidance Project of Lanzhou city [2019-ZD-68]

作者

  • L

    Li, Linjing (通讯) (第一作者)

    2 · lanzhou univ

  • L

    Li, Xin

    1 · southern med univ

查看全部 6 位作者收起作者
  • Z

    Zhang, Qingyan

    1 · sun yat sen univ

  • Y

    Ye, Tao

    1 · southern med univ

  • Z

    Zou, Shuli

  • Y

    Yan, Jing

    2 · lanzhou univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417